The partnership will develop a rice-based oral vaccine against cholera and E. coli-related diarrheal diseases.
In Southeast Asia, resistance is presumably due to the fact that there are far fewer cases of malaria so that selection pressure is greater.
Antibodies aren't enough—vaccines that also generate immune cells called CD8+ T cells can protect against malaria in the longer term.
Potential applications for the antimicrobial material include consumer and personal care products.
This kit improves on current methods by detecting Zika virus directly in the blood.
Subtropical and tropical countries with a history of mosquito-borne diseases have the greatest risk of the virus spreading once it hits the country.